Irving Bryan 4
4 · FIVE PRIME THERAPEUTICS INC · Filed Sep 5, 2017
Insider Transaction Report
Form 4
Irving Bryan
SVP, Research
Transactions
- Award
Employee Stock Option (right to buy)
2017-09-01+80,000→ 80,000 totalExercise: $0.00Exp: 2027-09-01→ Common Stock (80,000 underlying) - Award
Common Stock
2017-09-01+15,000→ 15,000 total
Footnotes (2)
- [F1]Represents shares of restricted stock, which will vest according to the following schedule: one-third (1/3) of the restricted stock will vest on each of September 1, 2018, 2019 and 2020, provided the reporting person remains employed by Five Prime Therapeutics, Inc. (the "Company") through each such date.
- [F2]One fourth (1/4th) of the shares underlying the option will vest on September 1, 2018, and the remainder of the shares underlying the option vest at a rate of one forth-eighth (1/48th) per month thereafter, provided the reporting person remains employed by the Company through each such date.